ros-responsive fluorescent small molecule hdb (BioMimetic Therapeutics)
90
Structured Review
BioMimetic Therapeutics
ros-responsive fluorescent small molecule hdb
Ros Responsive Fluorescent Small Molecule Hdb, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ros-responsive+fluorescent+small+molecule+hdb/ros+responsive+fluorescent+small+molecule+hdb/10__1016_slash_j__cej__2023__147515-2-4-29
Average 90 stars, based on 1 article reviews
Ros Responsive Fluorescent Small Molecule Hdb, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ros-responsive+fluorescent+small+molecule+hdb/ros+responsive+fluorescent+small+molecule+hdb/10__1016_slash_j__cej__2023__147515-2-4-29
Average 90 stars, based on 1 article reviews
ros-responsive fluorescent small molecule hdb - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Membrane:Article Title: Red blood cell membrane biomimetic nanoprobes for ratiometric imaging of reactive oxygen species level in atherosclerosis Article Snippet: Atherosclerosis (AS) is a major pathological factor to cardiovascular diseases, wherein reactive oxygen species (ROS) serve as the initiating link for the development of AS.. However, direct and accurate assessment of ROS levels in AS plaque sites remains challenging.. Herein, by embedding a ROS-responsive fluorescent small molecule (HDB with positive response or Cy7 with negative response) and a stable ROS-independent fluorescent dye CH1055 into red blood cell membrane (RBCM)-biomimetic liposomes, two biomimetic nanoprobes (R-Lipo@HDB/CH1055 and R-Lipo@Cy7/CH1055) were developed for indicating the existence of AS plaques and direct in situ ratiometric imaging of ROS at plaque sites. Liposomes:Article Title: Red blood cell membrane biomimetic nanoprobes for ratiometric imaging of reactive oxygen species level in atherosclerosis Article Snippet: Atherosclerosis (AS) is a major pathological factor to cardiovascular diseases, wherein reactive oxygen species (ROS) serve as the initiating link for the development of AS.. However, direct and accurate assessment of ROS levels in AS plaque sites remains challenging.. Herein, by embedding a ROS-responsive fluorescent small molecule (HDB with positive response or Cy7 with negative response) and a stable ROS-independent fluorescent dye CH1055 into red blood cell membrane (RBCM)-biomimetic liposomes, two biomimetic nanoprobes (R-Lipo@HDB/CH1055 and R-Lipo@Cy7/CH1055) were developed for indicating the existence of AS plaques and direct in situ ratiometric imaging of ROS at plaque sites. In Situ:Article Title: Red blood cell membrane biomimetic nanoprobes for ratiometric imaging of reactive oxygen species level in atherosclerosis Article Snippet: Atherosclerosis (AS) is a major pathological factor to cardiovascular diseases, wherein reactive oxygen species (ROS) serve as the initiating link for the development of AS.. However, direct and accurate assessment of ROS levels in AS plaque sites remains challenging.. Herein, by embedding a ROS-responsive fluorescent small molecule (HDB with positive response or Cy7 with negative response) and a stable ROS-independent fluorescent dye CH1055 into red blood cell membrane (RBCM)-biomimetic liposomes, two biomimetic nanoprobes (R-Lipo@HDB/CH1055 and R-Lipo@Cy7/CH1055) were developed for indicating the existence of AS plaques and direct in situ ratiometric imaging of ROS at plaque sites. Imaging:Article Title: Red blood cell membrane biomimetic nanoprobes for ratiometric imaging of reactive oxygen species level in atherosclerosis Article Snippet: Atherosclerosis (AS) is a major pathological factor to cardiovascular diseases, wherein reactive oxygen species (ROS) serve as the initiating link for the development of AS.. However, direct and accurate assessment of ROS levels in AS plaque sites remains challenging.. Herein, by embedding a ROS-responsive fluorescent small molecule (HDB with positive response or Cy7 with negative response) and a stable ROS-independent fluorescent dye CH1055 into red blood cell membrane (RBCM)-biomimetic liposomes, two biomimetic nanoprobes (R-Lipo@HDB/CH1055 and R-Lipo@Cy7/CH1055) were developed for indicating the existence of AS plaques and direct in situ ratiometric imaging of ROS at plaque sites. |